EUSA Pharma Ltd is a pharmaceutical manufacturing company located in Hemel Hempstead, England, operating under the regulatory number 09329429. Established on November 26th, 2014 and currently active, EUSA Pharma focuses primarily on biotechnology research and development within the pharmaceutical sector. The firm’s headquarters are situated at Breakspear Park, Hemel Hempstead, HP2 4TZ. EUSA Pharma specializes in providing bespoke services to clients involved in the creation of novel therapeutics and diagnostic tools through innovative biotechnological approaches. The company's core business encompasses custom synthesis, formulation development, and analytical testing – all designed to support early-stage research and potential commercialization efforts. They cater to a diverse range of pharmaceutical firms seeking collaborative partnerships for their projects. The company’s workforce comprises approximately 201-500 employees across various roles within its operational infrastructure. EUSA Pharma operates internationally, demonstrating a commitment to global business mobility through the designation of a Worker (A rating). Their strategic focus is on leveraging advanced biotechnological expertise to address evolving healthcare needs. EUSA Pharma’s SIC codes include: - 46460: Wholesale of pharmaceutical goods – indicating their role as distributors and suppliers of active pharmaceutical ingredients, intermediates, and excipients; - 72110: Research and experimental development on biotechnology – reflecting the company's investment in novel technologies and scientific advancements.

EUSA Pharma Ltd is a pharmaceutical manufacturing company located in Hemel Hempstead, England, operating under the regulatory number 09329429. Established on November 26th, 2014 and currently active, EUSA Pharma focuses primarily on biotechnology research and development within the pharmaceutical sector. The firm’s headquarters are situated at Breakspear Park, Hemel Hempstead, HP2 4TZ. EUSA Pharma specializes in providing bespoke services to clients involved in the creation of novel therapeutics and diagnostic tools through innovative biotechnological approaches. The company's core business encompasses custom synthesis, formulation development, and analytical testing – all designed to support early-stage research and potential commercialization efforts. They cater to a diverse range of pharmaceutical firms seeking collaborative partnerships for their projects. The company’s workforce comprises approximately 201-500 employees across various roles within its operational infrastructure. EUSA Pharma operates internationally, demonstrating a commitment to global business mobility through the designation of a Worker (A rating). Their strategic focus is on leveraging advanced biotechnological expertise to address evolving healthcare needs. EUSA Pharma’s SIC codes include: - 46460: Wholesale of pharmaceutical goods – indicating their role as distributors and suppliers of active pharmaceutical ingredients, intermediates, and excipients; - 72110: Research and experimental development on biotechnology – reflecting the company's investment in novel technologies and scientific advancements.